n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Status Epilepticus in 2 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
Status Epilepticus: A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tse, K | 1 |
| Hammond, D | 1 |
| Simpson, D | 1 |
| Beynon, RJ | 1 |
| Beamer, E | 1 |
| Tymianski, M | 1 |
| Salter, MW | 1 |
| Sills, GJ | 1 |
| Thippeswamy, T | 2 |
| Puttachary, S | 1 |
| Sharma, S | 1 |
| Verma, S | 1 |
| Yang, Y | 1 |
| Putra, M | 1 |
| Thippeswamy, A | 1 |
| Luo, D | 1 |
2 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Status Epilepticus
| Article | Year |
|---|---|
The impact of postsynaptic density 95 blocking peptide (Tat-NR2B9c) and an iNOS inhibitor (1400W) on proteomic profile of the hippocampus in C57BL/6J mouse model of kainate-induced epileptogenesis.
Topics: Amidines; Animals; Anticonvulsants; Benzylamines; Epilepsy; Hippocampus; Kainic Acid; Male; Mice, In | 2019 |
1400W, a highly selective inducible nitric oxide synthase inhibitor is a potential disease modifier in the rat kainate model of temporal lobe epilepsy.
Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Male; | 2016 |